[go: up one dir, main page]

DE60144383D1 - Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten - Google Patents

Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten

Info

Publication number
DE60144383D1
DE60144383D1 DE60144383T DE60144383T DE60144383D1 DE 60144383 D1 DE60144383 D1 DE 60144383D1 DE 60144383 T DE60144383 T DE 60144383T DE 60144383 T DE60144383 T DE 60144383T DE 60144383 D1 DE60144383 D1 DE 60144383D1
Authority
DE
Germany
Prior art keywords
preventing
methods
pain
spicamycin derivatives
spicamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60144383T
Other languages
English (en)
Inventor
David Borsook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE60144383D1 publication Critical patent/DE60144383D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60144383T 2000-09-20 2001-09-20 Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten Expired - Lifetime DE60144383D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23438200P 2000-09-20 2000-09-20
PCT/US2001/029371 WO2002024146A2 (en) 2000-09-20 2001-09-20 Methods of decreasing or preventing pain using spicamycin derivatives

Publications (1)

Publication Number Publication Date
DE60144383D1 true DE60144383D1 (de) 2011-05-19

Family

ID=22881151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60144383T Expired - Lifetime DE60144383D1 (de) 2000-09-20 2001-09-20 Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten

Country Status (9)

Country Link
US (3) US7196071B2 (de)
EP (2) EP1328236B1 (de)
JP (1) JP5016777B2 (de)
AT (1) ATE504302T1 (de)
AU (1) AU2001291133A1 (de)
CA (1) CA2425172C (de)
DE (1) DE60144383D1 (de)
ES (1) ES2365473T3 (de)
WO (1) WO2002024146A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60144383D1 (de) * 2000-09-20 2011-05-19 Gen Hospital Corp Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten
EP3175858B1 (de) * 2002-05-22 2019-08-21 Matsutani Chemical Industry Co., Ltd. Therapeutische verwendung von d-allose für die behandlung von leberkrebs oder hautkrebs
US7860552B2 (en) * 2004-10-01 2010-12-28 The Mclean Hospital Corporation CNS assay for prediction of therapeutic efficacy for neuropathic pain and other functional illnesses
JP5116071B2 (ja) 2005-07-20 2013-01-09 帝國製薬株式会社 Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用
WO2010042212A2 (en) 2008-10-10 2010-04-15 Dara Biosciences, Inc. Methods for treating or preventing pain using spicamycin derivatives
CN104822369A (zh) 2012-08-09 2015-08-05 达拉生物科学公司 包含穗霉素衍生物的组合物及其使用方法
US10262107B1 (en) * 2013-03-15 2019-04-16 Bao Tran Pharmacogenetic drug interaction management system
WO2015061481A1 (en) 2013-10-23 2015-04-30 Dara Biosciences, Inc. Methods of treating liquid tumors using compositions comprising spicamycin derivatives
US10732507B2 (en) 2015-10-26 2020-08-04 Esko-Graphics Imaging Gmbh Process and apparatus for controlled exposure of flexographic printing plates and adjusting the floor thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5252463A (en) * 1990-06-22 1993-10-12 The Du Pont Merck Pharmaceutical Company Clipsin, a chymotrypsin-like protease and method of using same
JP2783722B2 (ja) 1991-07-12 1998-08-06 麒麟麦酒株式会社 スピカマイシン誘導体およびそれを含む抗腫瘍剤
US5824645A (en) * 1991-12-30 1998-10-20 Neurex Corporation Method of treating inflammation
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5905069A (en) * 1998-01-26 1999-05-18 The General Hospital Corporation Methods of decreasing or preventing pain using spicamycin or derivatives thereof
DE60144383D1 (de) * 2000-09-20 2011-05-19 Gen Hospital Corp Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten

Also Published As

Publication number Publication date
EP1328236B1 (de) 2011-04-06
CA2425172C (en) 2011-02-01
US20070161597A1 (en) 2007-07-12
US7632825B2 (en) 2009-12-15
CA2425172A1 (en) 2002-03-28
AU2001291133A1 (en) 2002-04-02
EP1328236A2 (de) 2003-07-23
US7196071B2 (en) 2007-03-27
EP2305264A1 (de) 2011-04-06
JP2004537494A (ja) 2004-12-16
US20080207557A1 (en) 2008-08-28
ES2365473T3 (es) 2011-10-06
WO2002024146A2 (en) 2002-03-28
EP1328236A4 (de) 2005-10-26
JP5016777B2 (ja) 2012-09-05
WO2002024146A3 (en) 2003-05-22
WO2002024146A9 (en) 2004-05-13
ATE504302T1 (de) 2011-04-15
US7375094B2 (en) 2008-05-20
US20040038927A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
NO2022001I1 (no) Pazopanib
DE60108581D1 (de) Implantierbarer Herzschrittmacher
DE60010098D1 (de) 28-epirapaloge
UY25157A1 (es) Composiciones farmacéuticas conteniendo atorvastatina y amlodipino
ES2194180T3 (es) Nuevas fenantridinas.
PT1214936E (pt) Utilizacao de derivados de tiazolidina ou pirrolidina de aminoacidos como agentes anti-hiperglicemicos
DE60124021D1 (de) Implantierbare Stimulationsleitung
HRP20030831B1 (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
ATE344029T1 (de) Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern
HN1998000124A (es) Terapia de combinacion
EP1267918A4 (de) Behandlungsverfahren unter verwendung von ligand-immunogen-konjugaten
AR027355A1 (es) Acidos tiazolidincarboxilicos
DE60118544D1 (de) Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren
HK1053603A1 (en) Medicament based on gestagens for dermal application comprising ascorbic acid and/or salts thereof
AR032293A1 (es) Estuche farmaceutico
DE69814394D1 (de) Verwendung von levobupivacain
DE69919787D1 (de) Multi-Ort, parameter- gesteuerter, implantierbarer Herzschrittmacher / Defribrillator
HN1998000088A (es) Tratamiento de resistencia a la insulina
DE60105989D1 (de) Implantierbarer herzstimulator
DE60144383D1 (de) Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten
DK0380359T3 (da) Biocide midler og behandlingsfremgangsmåder
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
ATE368649T1 (de) Cyanoguanidin prodrugs
NO20005548L (no) Mykobakterieinhibitorer
DE60203267D1 (de) Implantierbarer herzstimulator